Luteal Phase Support With Progesterone Versus Estrogen & Progesterone on

Status Not yet recruiting

Clinical Trial Summary

This is a single center, 3 arms, prospective randomized controlled open study to determine the impact of luteal phase support on pregnancy rates in ovarian stimulation and IUI cycles with recombinant FSH in patients with unexplained infertility and mild male factor.

Patients will be randomized into 3 groups:

1. Luteal support with progesterone only (they will received vaginal P gel (Crinone 8% vaginal gel; Serono, Israel)

2. Luteal support with estrogen + progesterone [(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg].

3. No luteal support

Clinical Trial Description

Study design:

single center, 3 arms, prospective randomized controlled open study

Objective:

to determine the impact of luteal phase support on pregnancy rates in ovarian stimulation and IUI cycles with recombinant FSH in patients with unexplained infertility and mild male factor.

Methods:

All patients in all study groups will undergo a single insemination procedure and then will be randomized into 3 groups:

1. Luteal support with progesterone only (they will received vaginal P gel (Crinone 8% vaginal gel; Serono, Israel)

2. Luteal support with estrogen + progesterone [(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg].

3. No luteal support

Luteal support will begin after insemination and will be continued through the 12th week of gestation if the patient conceived. A pregnancy test will be performed 2 weeks after insemination (Serum hCG) an intrauterine pregnancy will be confirmed using a transvaginal ultrasound 2 weeks after a positive pregnancy test. If no pregnancy will be achieved patients will undergo 3 treatment cycles preferably in the same treatment group. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01237535
Study type	Interventional
Source	Rabin Medical Center
Contact	Galia Oron
Phone	972-3-9377492
Email	orong@clalit.org.il
Status	Not yet recruiting
Phase	Phase 4
Start date	November 2011
Completion date	November 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04169451` - IUI With Letrozole Versus in Natural Cycle	N/A
Completed	`NCT01672801` - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT	N/A
Completed	`NCT01232465` - Impact of Sperm DNA Integrity on In Vitro Cycles	N/A
Completed	`NCT02272439` - Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan	N/A
Terminated	`NCT00650754` - Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility	Phase 2/Phase 3
Recruiting	`NCT04754243` - New Protocol in Unexplained Infertility	Phase 4
Completed	`NCT03018314` - Serum Kisspeptin Levels in Infertile Women	N/A
Completed	`NCT02488434` - The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility	Phase 3
Completed	`NCT02739516` - Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility	Phase 3
Completed	`NCT02628756` - Endometrial Injury in Women With Unexplained Infertility	N/A
Completed	`NCT01044862` - Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation	Phase 3
Recruiting	`NCT03386552` - A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility	Phase 2
Completed	`NCT04465045` - Unexplained Infertility Treated by Hysteroscopy-laparoscopy
Completed	`NCT03461601` - Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility	N/A
Completed	`NCT01859520` - Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa	N/A
Active, not recruiting	`NCT03828786` - Uterine Scratching in Intra-Uterine Insemination	N/A
Completed	`NCT03397693` - Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
Withdrawn	`NCT04955574` - Probiotic and Antibiotic Therapies in Women With Unexplained Infertility	Phase 2
Not yet recruiting	`NCT03398993` - Effect of Endometrial Injury in Couples With Unexplained Infertility	N/A
Completed	`NCT02861105` - The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms